Covid-19 tests versus Omicron
The new variant might be able to dodge one of the PCR tests authorised in the US, the FDA says.
The new reality of Covid-19 testing
An evolving virus demands innovative diagnostic technologies.
Diasorin heads to the US with $1.8bn Luminex deal
And consolidation in the diagnostics space is only just beginning.
Medtech’s haves and have-nots
Medtronic’s quarterly results yesterday might presage a recovery, and some groups are in dire need of one.
Thermo Fisher and the new variant
Pinpointing new forms of the coronavirus could be vital, particularly if it mutates in response to vaccination, the company says.